Assembly Biosciences Debt 2024

Assembly Biosciences Aktienanalyse

What does Assembly Biosciences do?

Assembly Biosciences Inc is an innovative biotechnology company specializing in the development of new therapies for infectious diseases and gastrointestinal disorders. The company was founded in 2005 and is headquartered in South San Francisco, California. The company's business model focuses on the discovery and development of new drugs for infectious diseases and gastrointestinal disorders, with a goal of establishing a strong pipeline of innovative therapeutics. The company's research activities are divided into two main areas: infectious diseases and gastrointestinal disorders. The company currently has no products on the market but is in the development phase of its pipeline. Assembly Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Assembly Biosciences's Debt Structure

Assembly Biosciences's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Assembly Biosciences's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Assembly Biosciences’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Assembly Biosciences’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Assembly Biosciences stock

What is the debt of Assembly Biosciences this year?

Assembly Biosciences has a debt level of -19.84 USD this year.

What was the debt of Assembly Biosciences compared to the previous year?

The debt of Assembly Biosciences has increased by -62.15% compared to the previous year dropped.

What are the consequences of high debt for investors in Assembly Biosciences?

High debt can pose a risk for investors of Assembly Biosciences, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Assembly Biosciences?

Low debt means that Assembly Biosciences has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Assembly Biosciences affect the company?

An increase in debt of Assembly Biosciences can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Assembly Biosciences affect the company?

A reduction in debt of Assembly Biosciences can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Assembly Biosciences?

Some factors that can influence the debt of Assembly Biosciences include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Assembly Biosciences so important for investors?

The debts of Assembly Biosciences are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Assembly Biosciences take to change the debt?

To change the debt, Assembly Biosciences can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Assembly Biosciences pay?

Over the past 12 months, Assembly Biosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Assembly Biosciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Assembly Biosciences?

The current dividend yield of Assembly Biosciences is .

When does Assembly Biosciences pay dividends?

Assembly Biosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Assembly Biosciences?

Assembly Biosciences paid dividends every year for the past 0 years.

What is the dividend of Assembly Biosciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Assembly Biosciences located?

Assembly Biosciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Assembly Biosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Assembly Biosciences from 9/22/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/22/2024.

When did Assembly Biosciences pay the last dividend?

The last dividend was paid out on 9/22/2024.

What was the dividend of Assembly Biosciences in the year 2023?

In the year 2023, Assembly Biosciences distributed 0 USD as dividends.

In which currency does Assembly Biosciences pay out the dividend?

The dividends of Assembly Biosciences are distributed in USD.